MA26558A1 - Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. - Google Patents

Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.

Info

Publication number: MA26558A1
Authority: MA; Morocco
Prior art keywords: methylerythromycin; derivatives; novel; preparation; pharmaceutical compositions
Prior art date: 1997-10-29

Application number

MA25314A

Other languages

English (en)

Inventor

Wu Yong-Jin

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-29

Filing date

1998-10-26

Publication date

2004-12-20

1998-10-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-12-20 Publication of MA26558A1 publication Critical patent/MA26558A1/fr

Links

AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

MA25314A 1997-10-29 1998-10-26 Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. MA26558A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6367697P	1997-10-29	1997-10-29

Publications (1)

Publication Number	Publication Date
MA26558A1 true MA26558A1 (fr)	2004-12-20

Family

ID=22050768

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25314A MA26558A1 (fr)	1997-10-29	1998-10-26	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.

Country Status (13)

Country	Link
US (1)	US6159945A (fr)
AP (1)	AP9801378A0 (fr)
AR (1)	AR017177A1 (fr)
AU (1)	AU9277698A (fr)
CO (1)	CO4810375A1 (fr)
GT (1)	GT199800163A (fr)
HN (1)	HN1998000159A (fr)
HR (1)	HRP980571A2 (fr)
MA (1)	MA26558A1 (fr)
PA (1)	PA8461701A1 (fr)
PE (1)	PE122499A1 (fr)
TN (1)	TNSN98194A1 (fr)
WO (1)	WO1999021866A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6710033B1 (en)	1996-08-14	2004-03-23	Vanderbilt University	Methods and treatment of multiple sclerosis
US6890526B2 (en)	1997-05-06	2005-05-10	Vanderbilt University	Methods and reagents for the treatment of multiple sclerosis
AP9801420A0 (en) *	1998-01-02	1998-12-31	Pfizer Prod Inc	Novel macrolides.
US6248719B1 (en)	1998-06-03	2001-06-19	Pfizer Inc	Tricyclic 3-keto derivatives of 6-O-methylerthromycin
ATE344269T1 (de) *	1998-12-10	2006-11-15	Pfizer Prod Inc	Carbamat und carbazat ketolid antibiotika
EP1298138B1 (fr) *	1998-12-10	2006-11-02	Pfizer Products Inc.	Dérivés anitiobiotiques de Carbamate et de Carbazate Kètolides
DK1147121T3 (da)	1999-01-27	2004-04-13	Pfizer Prod Inc	Ketolidantibiotika
EE200100613A (et) *	1999-05-24	2003-02-17	Pfizer Products Inc.	13-metüülerütromütsiini derivaadid
ID27331A (id) *	1999-09-29	2001-03-29	Pfizer Prod Inc	Pembuatan antibiotik-antibiotik ketolida karbamat
US6498146B1 (en) *	1999-10-28	2002-12-24	Pfizer Inc	Erythromycin derivatives
EP1146051A3 (fr) *	2000-04-10	2001-10-31	Pfizer Products Inc.	Dérivées de l' érythromycine A
US20020115621A1 (en) *	2000-08-07	2002-08-22	Wei-Gu Su	Macrolide antibiotics
US20070003508A1 (en)	2005-07-01	2007-01-04	Wooley Richard E	Methods and compositions for promoting wound healing
US20040208842A1 (en) *	2001-09-18	2004-10-21	Ritchie Branson W.	Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) *	2001-09-18	2004-08-05	Ritchie Branson W.	Methods and compositions for wound management
US7601695B2 (en)	2003-03-10	2009-10-13	Optimer Pharmaceuticals, Inc.	Antibacterial agents
US20070185202A1 (en) *	2004-03-03	2007-08-09	University Of Georgia Research Foundation, Inc.	Methods and compositions for ophthalmic treatment of fungal and bacterial infections
SI1836211T1 (sl)	2004-12-21	2010-04-30	Pfizer Prod Inc	Makrolidi
AU2008316830B2 (en)	2007-10-25	2016-03-17	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
CN107854477A (zh)	2008-10-24	2018-03-30	森普拉制药公司	使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
US9480679B2 (en)	2009-09-10	2016-11-01	Cempra Pharmaceuticals, Inc.	Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr)	2010-03-22	2016-03-25	Cempra Pharmaceuticals Inc	Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt)	2010-05-20	2016-08-02	Cempra Pharmaceuticals Inc	processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko)	2010-09-10	2013-11-04	셈프라 파마슈티컬스, 인크.	질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (fr)	2012-03-27	2013-10-03	Cempra Pharmaceuticals, Inc.	Formulations parentérales pour l'administration d'antibiotiques macrolides
WO2014152326A1 (fr)	2013-03-14	2014-09-25	Cempra Pharmaceuticals, Inc.	Procédés pour traiter des maladies respiratoires et formulations pour la mise en œuvre de ceux-ci
AU2014233240B2 (en)	2013-03-15	2018-08-09	Cempra Pharmaceuticals, Inc.	Convergent processes for preparing macrolide antibacterial agents
EP4095146A1 (fr)	2013-04-04	2022-11-30	President And Fellows Of Harvard College	Macrolides et leurs procédés de préparation et d'utilisation
JP2017531663A (ja)	2014-10-08	2017-10-26	プレジデントアンドフェローズオブハーバードカレッジ	１４員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (fr)	2015-03-25	2016-09-29	President And Fellows Of Harvard College	Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US6060234A (en) *	1991-01-17	2000-05-09	Abbott Laboratories	Polyketide derivatives and recombinant methods for making same
ES2087737T3 (es) *	1992-04-22	1996-07-16	Taisho Pharmaceutical Co Ltd	Un derivado 5-o-desosaminil-eritronoluro a.
WO1998051696A1 (fr) *	1997-05-09	1998-11-19	Pfizer Products Inc.	Derives d'erythromycine
KR20010013660A (ko) *	1997-06-11	2001-02-26	실버스타인 아써 에이.	9-옥심 에리트로마이신 유도체

1998
- 1998-10-08 HN HN1998000159A patent/HN1998000159A/es unknown
- 1998-10-09 US US09/402,338 patent/US6159945A/en not_active Expired - Fee Related
- 1998-10-09 AU AU92776/98A patent/AU9277698A/en not_active Abandoned
- 1998-10-09 WO PCT/IB1998/001578 patent/WO1999021866A1/fr not_active Ceased
- 1998-10-16 PA PA19988461701A patent/PA8461701A1/es unknown
- 1998-10-22 PE PE1998000993A patent/PE122499A1/es not_active Application Discontinuation
- 1998-10-23 GT GT199800163A patent/GT199800163A/es unknown
- 1998-10-26 TN TNTNSN98194A patent/TNSN98194A1/fr unknown
- 1998-10-26 MA MA25314A patent/MA26558A1/fr unknown
- 1998-10-27 AR ARP980105379A patent/AR017177A1/es not_active Application Discontinuation
- 1998-10-29 AP APAP/P/1998/001378A patent/AP9801378A0/en unknown
- 1998-10-29 CO CO98063687A patent/CO4810375A1/es unknown
- 1998-10-29 HR HR60/063,676A patent/HRP980571A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
PA8461701A1 (es)	2000-05-24
WO1999021866A1 (fr)	1999-05-06
US6159945A (en)	2000-12-12
PE122499A1 (es)	1999-12-02
AR017177A1 (es)	2001-08-22
HRP980571A2 (en)	1999-08-31
GT199800163A (es)	2000-04-15
CO4810375A1 (es)	1999-06-30
AP9801378A0 (en)	2000-04-29
HN1998000159A (es)	1999-02-09
AU9277698A (en)	1999-05-17
TNSN98194A1 (fr)	2005-03-15

Similar Documents

Publication	Publication Date	Title
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26424A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26680A1 (fr)	2004-12-20	Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
MA26479A1 (fr)	2004-12-20	Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26425A1 (fr)	2004-12-20	Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26505A1 (fr)	2004-12-20	Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26438A1 (fr)	2004-12-20	Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26471A1 (fr)	2004-12-20	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26614A1 (fr)	2004-12-20	Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2735777B1 (fr)	1997-09-12	Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26508A1 (fr)	2004-12-20	Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26740A1 (fr)	2004-12-20	Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26519A1 (fr)	2004-12-20	Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26624A1 (fr)	2004-12-20	Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant